This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. ICU Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $97.667. ICU Medical's 10-Year median PS Ratio is 3.5845. Therefore, the Median PS Value for today is $350.09.
As of today (2025-03-30), ICU Medical's share price is $140.16. ICU Medical's Median PS Value is $350.09. Therefore, ICU Medical's Price to Median PS Value for today is 0.40.
The historical rank and industry rank for ICU Medical's Median PS Value or its related term are showing as below:
ICUI'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29 Med: 1.07 Max: 2.39
Current: 0.4
During the past 13 years, the highest Price to Median PS Value of ICU Medical was 2.39. The lowest was 0.29. And the median was 1.07.
ICUI's Price-to-Median-PS-Value is ranked better than 79.8% of 302
companies
in the Medical Devices & Instruments industry
Industry Median: 0.76
vs ICUI: 0.40
ICU Medical Median PS Value Historical Data
The historical data trend for ICU Medical's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ICU Medical's Median PS Value
For the Medical Instruments & Supplies subindustry, ICU Medical's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where ICU Medical's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.5845.
ICU Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $97.667.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (NAS:ICUI) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
ICU Medical's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
140.16
/
350.09
=
0.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical Median PS Value Related Terms
Thank you for viewing the detailed overview of ICU Medical's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICUI has been successfully added to your 